Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care
Novo Nordisk commits USD 200 million over 10 years to help the World Diabetes Foundation strengthen diabetes prevention and care in underserved communities
Covered in this story
Call it yourself
No calls on $NOVO-B.CO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Novo Nordisk →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.